# Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"

> **NCT03071809** · — · TERMINATED · sponsor: **Lexent Bio, Inc.** · enrollment: 5 (actual)

## Conditions studied

- Neoplasms, Non-hematologic - Stage I-III

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03071809
- **Lead sponsor:** Lexent Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-30
- **Primary completion:** 2019-03-15
- **Final completion:** 2019-03-15
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Accrual difficulties
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03071809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03071809, "Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03071809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*